GSA Capital Partners’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-399,039
| Closed | -$475K | – | 2035 |
|
|
2022
Q3 | $475K | Buy |
+399,039
| New | +$475K | 0.06% | 607 |
|
|
2021
Q1 | – | Sell |
-20,706
| Closed | -$99K | – | 1615 |
|
|
2020
Q4 | $99K | Buy |
+20,706
| New | +$99K | 0.02% | 1100 |
|
|
2020
Q2 | – | Sell |
-15,576
| Closed | -$99K | – | 1255 |
|
|
2020
Q1 | $99K | Sell |
15,576
-3,906
| -20% | -$24.8K | 0.02% | 899 |
|
|
2019
Q4 | $203K | Sell |
19,482
-7,696
| -28% | -$80.2K | 0.02% | 1250 |
|
|
2019
Q3 | $107K | Buy |
+27,178
| New | +$107K | 0.01% | 1269 |
|
|
2015
Q3 | – | Sell |
-14,000
| Closed | -$1.23M | – | 2093 |
|
|
2015
Q2 | $1.23M | Buy |
14,000
+7,691
| +122% | +$676K | 0.05% | 724 |
|
|
2015
Q1 | $468K | Buy |
+6,309
| New | +$468K | 0.02% | 1429 |
|
|
2014
Q1 | – | Sell |
-5,637
| Closed | -$340K | – | 1860 |
|
|
2013
Q4 | $340K | Buy |
5,637
+637
| +13% | +$38.4K | 0.03% | 1111 |
|
|
2013
Q3 | $304K | Buy |
+5,000
| New | +$304K | 0.02% | 1142 |
|